Oncology

BTK Inhibitors in CLL: New Clinical Evidence Reshapes First-Line Treatment

by Nancy Ogbonna - 0259

BTK Inhibitors in CLL: New Clinical Evidence Reshapes First-Line Treatment   Please like and subscribe if you enjoyed this video :-)   Introduction The treatment landscape for chronic lymphocytic leukemia (CLL), the most common leukemia in Western countries, has undergone a major shift with the advent of Bruton’s tyrosine kinase

Monoclonal Antibodies in Relapsed Multiple Myeloma: The Era of Bispecifics and Beyond

by Nancy Ogbonna - 0212

Monoclonal Antibodies in Relapsed Multiple Myeloma: The Era of Bispecifics and Beyond   Check back later for a possible video summary. Videos are created for most articles.   Abstract This paper provides an in-depth review of monoclonal antibody (mAb) therapies in the treatment of relapsed multiple myeloma (MM), with a particular focus on bispecific antibodies

Hidden Signs of GATA2 Deficiency: Why Doctors Miss This Rare Disorder

by Nancy Ogbonna - 078

Hidden Signs of GATA2 Deficiency: Why Doctors Miss This Rare Disorder   Check back later for a possible video summary. Videos are created for most articles.     Introduction GATA2 deficiency is the most common hereditary predisposition to pediatric myelodysplastic syndrome (MDS), yet it remains one of the most frequently overlooked genetic disorders in clinical practice. This

Cancer Vaccines for Treatment: Breaking Through Scientific Barriers in 2025

by Nancy Ogbonna - 0180

Cancer Vaccines for Treatment: Breaking Through Scientific Barriers in 2025 Please like and subscribe if you enjoyed this video :-)   Introduction Cancer vaccines have emerged as a transformative innovation in oncology, offering a new layer of precision in

New Anticoagulants vs LMWH in Cancer-Associated Thrombosis: Latest Evidence

by Nancy Ogbonna - 0149

New Anticoagulants vs LMWH in Cancer-Associated Thrombosis: Latest Evidence Please like and subscribe if you enjoyed this video :-)   Introduction Venous thromboembolism (VTE), encompassing deep vein thrombosis and pulmonary embolism, remains one of the most common and life-threatening complications in patients with cancer.

JAK2, CALR, and MPL Mutations: Advanced Treatment Strategies That Work

by Nancy Ogbonna - 0280

JAK2, CALR, and MPL Mutations: Advanced Treatment Strategies That Work Please like and subscribe if you enjoyed this video :-)    Introduction The discovery of somatic mutations in the JAK2, CALR, and MPL genes has transformed the diagnostic and therapeutic landscape

Breaking the Myth: Delayed Intensification Side Effects in Modern ALL Treatment (2025 Update)

by Nancy Ogbonna - 0261

Breaking the Myth: Delayed Intensification Side Effects in Modern ALL Treatment (2025 Update) Please like and subscribe if you enjoyed this video :-)   Introduction Delayed intensification therapy has long been a cornerstone in the treatment of pediatric acute lymphoblastic leukemia (ALL),

Hidden First Signs of Leukemia That Doctors Often Miss in Primary Care

by Nancy Ogbonna - 0280

Hidden First Signs of Leukemia That Doctors Often Miss in Primary Care Please like and subscribe if you enjoyed this video :-)   Introduction Leukemia accounts for approximately 3.2% of all new cancer cases in the U.S., yet its early signs

Why MDS Can Be Misdiagnosed: Hidden Links to Pernicious Anemia

by Nancy Ogbonna - 0317

Why MDS Can Be Misdiagnosed: Hidden Links to Pernicious Anemia Please like and subscribe if you enjoyed this video :-)   Introduction Vitamin B12 deficiency is a growing concern, especially among older adults. In the U.S. and UK, it affects roughly

BTK Inhibitors in CLL: New Clinical Evidence Reshapes First-Line Treatment